usually have myelitis and characteristically have asymmetric clinical with predominantly sensory symptoms. Spinal MRI lesions usually extend than spinal   segments. subtypes of CIS, abnormal brain MRI results is the most robust factor to predict conversion, followed by the presence of OBs.25,28,29 Notably, none of our 20 patients   with and normal baseline  MRI results has experienced development of second attack Or new T2 lesion in the MRI after mean follow-up of 44 months (data not shown) partial findings myelitis 1-year

CISs classically refer to ON, brainstem syndromes, Or spinal  cord syndromes. Less common initial   episodes suggestive of central nervous system demyelina tion such as hemispheric Or clinically   polyregional syndromes have not been specifically studied.  In cohort, only 30 patients (9.4%) had an initial attack different from classical CISs: 12 patients (3.8%) had polyregional   syndrome, 6 had hemispheric  syndrome (1.9%), and 12 (3.8%) had neurological syndrome of undetermined topography. In our cohort of patients,   there group of patients to draw useful conclusions. A con sensus definition of what is multifocal or polyregional needs to be achieved, and greater

The  apparent   discrepancy  between  natural  history has better outcome and the prospective cohort on CISs and clinical trials that do not show differences in outcomes among diftional study, which demonstrates that, overall, may have better outcome because, as group, more chances for normal ferential   diagnosis   in   patients   with subacute visual loss   is comprehensible, and other mimic inflammatory-demyelinating ON are difficult to identify. Nevertheless, if a patient with ON has abnormal baseline MRI results, his Or her prognosis  does not differ from that of other patients with different CISs. MRI at baseline; not CIS topography, appears to be the crucial issue at MS presentation. they have base-

## References

- 1 Confavreux C, Vukusic $, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnestic process.  Brain 2003,126.770-782
- 2 The natural of multiple   sclerosis: geographically based study . Clinical history
- 3 Weinshenker BG Natural History
- Runmarker B, Andersen 0. Prognostic factors in multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993,116.117-134.

- 5. Brex PA, Ciccarelli O, Jonathon I, et al. A longitudinal study of abnormalities on N Engl J Med 2002,346:158-164.
- 6. Morrissey SP The significance of brain magnetic resonance imaging abnormalities at presentation multiple sclerosis. 135-146.
- 7 The progthe CNS: a 10 year follow-up. Brain 1998,121:495-503.
- 8. Jacobs LD Beck RW, Simon JH, et al. Intramuscular interferon-beta-Ia therapy initiated first demyelinat event in multiple   sclerosis. N Engl J Med 2000,343: 898-904 during ing
- 9 Comi G, Filippi M, Barkhof F, et al. treatment on conversion to  definite  multiple   sclerosis: randomized study. Lancet 2001,357.1576-1582
- 10. Tintoré  M, Rovira A Rio J, et al Optic   neuritis   brainstem syndromes   and myelitis:   early conversion to multiple sclerosis Med Clin (Barc) 1999,112.693-694
- 11. Tintoré M, Rovira A Rio J, et al. New diagnostic criteria for multiple   sclerosis: application in first   demyelinating episode.
- 12 Frohman EM, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS. Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2003,61.602-611.
- 13 McDonald WI,  Compston A Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international Ann Neurol 2001,50:121-127 panel
- 14.  Andersson M, Alvarez-Cermeño J , Bernardi G, spinal   fluid in consensuS report. J Neurol   Neurosurg   Psychiatry 1994,57:897 \_ 902
- 15. Barkhof F, Filippi M, et al. Comparison of MRI criteria at first   presentation to predict  conversion to clinically definite multiple sclerosis.  Brain 1997,120.2059-2069.
- 16. Poser CM, DW, Scheinberg L, et al. New diagnostic criAnn Neurol 1983,13.227-231 Paty
- 17. syndromes: comparison of different MRI criteria to predict conversion to Am ing
- 18. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute neuritis. The Med 1992,27.581-588 optic Group.
- 20. M,  Siva A Cross SA, al. Optic neuritis: Neu Rodriguez rology
- 19. Rio J, Nos C, Rovira A, et al. The development of multiple sclerosis   following an isolated of neuritis Magnetic resonance 372. episode optic
- 21 . of multiple  sclerosis   after neuritis. Neurol   Neurosurg optic
- 22 Söderström M, J, Hillert  J, Link H Prognosis for multiple sclerosis from MRI, CSF and HLA findNeurology 1998,50.708-714. Ya-Ping ings.
- et al. Correlation of clinical, MRI and CSF in findings optic